Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by JLGeminion Sep 16, 2010 5:59pm

282 Views

Post# 17458123

RE: RE: Welcome - Sharkfood - Which M?

Sharkfood. I am an investor and a person. I have lost my mother and sister to cancer. I have the right to hope for a "possible" cure. Oncolytics has never made a claim to be a cure. If you read their disclaimers, you can accuse Oncolytics of over selling. Their sales pitch is: "You do want to thake the risk."

Why do you not sell at the current high?

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario